Michael Megna sold $1.1M of KNSA stock
By AlphaYouPublished Form 4
Megna Michael R
Reporting filer
Michael Megna reported selling 11,280 shares of Kiniksa Pharmaceuticals International, plc for about $1.1M ($98.54 a share on average). Form 4 filed Nov 12, 2026 lists 3 entries.
See the price move since this trade →
- Disclosed
- Nov 12, 2026
Reported details
3 entries| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Class A Ordinary Share | Megna Michael R | 2026-11-09 | M | Exercise or conversion | 11280 | 17.76 | 23,977 | 3 days | Filed terms
|
| Class A Ordinary Share | Megna Michael R | 2026-11-09 | S | Sale | 11280 | 98.54 | 12,697 | 3 days | Filed terms
|
| Share Option (derivative) | Megna Michael R | 2026-11-09 | M | Exercise or conversion | 11280 | 0 | 5,114 | 3 days | Filed terms
|
Class A Ordinary Share
- Owner
- Megna Michael R
- Date
- 2026-11-09
- Code
- M
- Action
- Exercise or conversion
- Quantity
- 11280
- Price
- 17.76
- Following holdings
- 23,977
- Reporting delay
- 3 days
- Filed terms and references
Filed terms
- security Title: Class A Ordinary Share
- transaction Date: 2026-11-09
- transaction Form Type: 4
- transaction Code: M
- equity Swap Involved: 0
- id: F1
- transaction Shares: 11280
- transaction Price Per Share: 17.76
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 23977
- direct Or Indirect Ownership: D
- nature Of Ownership:
Class A Ordinary Share
- Owner
- Megna Michael R
- Date
- 2026-11-09
- Code
- S
- Action
- Sale
- Quantity
- 11280
- Price
- 98.54
- Following holdings
- 12,697
- Reporting delay
- 3 days
- Filed terms and references
Filed terms
- security Title: Class A Ordinary Share
- transaction Date: 2026-11-09
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- id: F1
- transaction Shares: 11280
- transaction Price Per Share: 98.54
- id: F2
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 12697
- direct Or Indirect Ownership: D
- nature Of Ownership:
Share Option (derivative)
- Owner
- Megna Michael R
- Date
- 2026-11-09
- Code
- M
- Action
- Exercise or conversion
- Quantity
- 11280
- Price
- 0
- Following holdings
- 5,114
- Reporting delay
- 3 days
- Filed terms and references
Filed terms
- security Title: Share Option
- conversion Or Exercise Price: 17.76
- transaction Date: 2026-11-09
- transaction Form Type: 4
- transaction Code: M
- equity Swap Involved: 0
- id: F1
- transaction Shares: 11280
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: D
- id: F3
- expiration Date: 2033-08-31
- underlying Security Title: Class A Ordinary Share
- underlying Security Shares: 11280
- shares Owned Following Transaction: 5114
- direct Or Indirect Ownership: D
- nature Of Ownership:
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Megna Michael R: CHIEF ACCOUNTING OFFICER.
- The filing reports a Rule 10b5-1 trading plan.
- F1: This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on July 30, 2026.
- F2: This transaction was executed in multiple trades through a broker-dealer at prices ranging between $98.48 and $98.64. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
- F3: The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is September 1, 2023.
Original sources
Prepared automatically from public filing data. Report a correction.